MAPT and Alzheimer disease: Comparing marker levels in cases on the AD continuum with cases with stable negative biomarkers and normal cognition, we ask how innate immune activation is linked to Ab and tau pathology at the main stages of the pre-dementia AD continuum, and in non-AD cases with abnormal tau markers.